Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07501663 · ClinicalTrials.gov registry record · NA

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target

NCT07501663 is a NA study that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07501663, a NA study, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The objective of the proposed pilot is to test the feasibility, acceptability, and preliminary efficacy of a 16-week sequential, multiple assessment randomized trial (SMART), which includes virtual Tai Chi/Qi Gong or α- Lipoic acid (ALA) supplements as an initial treatment, and acupuncture as the additional treatment, that examines a stepped-care intervention to address CIPN.

Interventions

  • PROCEDURE Acupuncture
  • BEHAVIORAL Tai Chi/Qi Gong
  • DIETARY_SUPPLEMENT α- Lipoic acid

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-01-20
Est. Completion 2027-04
Phase NA

What the Registry Record Tells You About NCT07501663

The ClinicalTrials.gov registry entry for NCT07501663 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Acupuncture is the first listed.

NCT07501663 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07501663 about?

NCT07501663 is a clinical study titled "Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study". The objective of the proposed pilot is to test the feasibility, acceptability, and preliminary efficacy of a 16-week sequential, multiple assessment randomized trial (SMART), which includes virtual Tai Chi/Qi Gong or α- Lipoic acid (ALA) supplements as an initial treatment, and acupuncture as the ad...

What is the current status of trial NCT07501663?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-20. Estimated completion is 2027-04.

What interventions are being tested in trial NCT07501663?

The interventions under investigation include: Acupuncture (PROCEDURE), Tai Chi/Qi Gong (BEHAVIORAL), α- Lipoic acid (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07501663?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.